March 22, 2006—GlaxoSmithKline is tagging bottles of HIV med Trizivir with tiny silicon chips to protect the patent and prevent counterfeiting. The FDA has asked pharmaceutical companies to develop drug-tracking technology in hopes of implementing such a system widely in the next few years on a range of medications.